<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-142953</identifier>
<setSpec>0212-1611</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Challenges in the treatment of patients with type 2 diabetes mellitus and obesity</dc:title>
<dc:description xml:lang="en">The current treatment of obesity generally fails in the long term and the optimized control of diabetes represents a difficult challenge requiring a multi-disciplinary approach and a high degree of motivation by the therapeutic team, the patient and the patient&#149;s family. When diabetes is associated with obesity, quite a frequent phenomenon, the treatment of these patients represents a true clinical challenge. Although far from perfect, there are currently several therapeutic weapons available in the armoury. Non- pharmacological treatment, fundamentally a low calorie diet and its multiple variations, anti-glycaemia and anti-obesity drugs, and surgical treatment or a combination of these therapeutic strategies present various difficulties and pose several questions. The characteristics of each are analyzed with their pros and cons and their implication in weight loss, control of glycaemia, reduction in the associated cardiovascular risk factors, morbidity and mortality (AU)</dc:description>
<dc:creator>Manzanares Errazu, JM</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El tratamiento actual de la obesidad fracasa a largo plazo de forma habitual y el control optimizado de la diabetes representa un reto difícil que requiere una aproximación interdisciplinaria y una alta motivación por parte del equipo terapéutico y del paciente y su familia. Cuando se combina obesidad y diabetes, lo cual es francamente frecuente, el tratamiento de estos pacientes representa un auténtico desafío clínico. Aunque francamente imperfectas, existen actualmente diversas armas terapéuticas a utilizar. El tratamiento no farmacológico, básicamente la dieta hipocalórica y sus diversas variantes, los fármacos antidiabéticos y antiobesidad y el tratamiento quirúrgico y la combinación de estas estrategias terapéuticas presentan múltiples dificultades y plantean diversas preguntas. Se analizan sus características, pros y contras y su implicación en disminución de peso, control glucémico, reducción de los diversos factores de riesgo cardiovascular asociados, morbilidad y mortalidad (AU)</dc:description>
<dc:source>Nutr Hosp;17(supl.1): 1-6, 2002.</dc:source>
<dc:identifier>ibc-142953</dc:identifier>
<dc:title xml:lang="es">Desafíos en el tratamiento del paciente con diabetes mellitus tipo 2 y obesidad</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d7182^s22044</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d9951^s22057</dc:subject>
<dc:subject>^d9951^s22017</dc:subject>
<dc:subject>^d51221^s22045</dc:subject>
<dc:subject>^d33085^s22044</dc:subject>
<dc:subject>^d7182^s22073</dc:subject>
<dc:subject>^d3946^s22017</dc:subject>
<dc:subject>^d33085^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>200200</dc:date>
</metadata>
</record>
</ibecs-document>
